DERPHARTOX

Derphartox is dedicated to developing alternative methods for toxicity testing and drug development and has developed alternative methods for screening dermal irritants and contact allergens and measuring rates of percutaneous penetration. These methods are at least as reliable, and in some cases better, than current animal tests... Where animals still need to be used, e.g. human disease models, Derphartox is actively investigating alternatives which can be used to predict efficacy and safety in patients... Derphartox is a Contract Research Organization, based in The Netherlands, which specializes in pre-clinical skin research. Its mission is to provide companies with information on the safety and efficacy of lead compounds which can be used to support any decision to proceed to clinical studies. Derphartox does this by using in vitro and in vivo models which have been shown to be reliable indicators of toxicity and efficacy in man.

Also known as: Derphartox BV

Primary location: Rotterdam Netherlands